Abstract
Both statisticians and drug companies are often surprised and, perhaps, disappointed to find that clinicians do not always translate the apparently clear-cut results of clinical trials into their daily practice. In this presentation, I will endeavour to examine why it is that physicians, in general, and cardiologists in particular, are, and indeed should be, hesitant about extrapolating from published trials into real life.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilhelmsson C, Vedin JA, Wilhelmsen L, Tibblin G, Werko L. 1974. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet 11: 1157–1159.
Baber NS, Wainwright Evans D, Howitt G, Thomas M, Wilson C, Lewis JA, Dawes PM, Handler K, Tuson R. 1980. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. British Heart Journal 44: 96–100.
Anturane Reinfarction Trial Research Group (ART). 1980. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. New England Journal of Medicine 302: 250–256.
Multicentre International Study. 1977. Supplementary report–Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. British Medical Journal 2: 419–421.
European Coronary Surgery Study Group. 1980. Prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 11: 491–495.
Chamberlain DA, Jewitt DE, Julian DG, Campbell RWF, Boyle DMcC, Shanks RG et al. 1980. Oral mexiletine in high-risk patients after myocardial infarction. Lancet ii: 1324–1327.
Roden DM, Reele SB, Higgins SB, Mayol RF, Gammans RE, Oates JA, Woosley RL. 1980. Total suppression of ventricular arrhythmias by encainide. New England Journal of Medicine 302: 877–882.
Anderson, JL, Stewart JR, Perry BA, van Hamersveld DD, Johnson TA, Conard GJ, Chang SF, Kvam DC, Pitt B. 1981. Oral flecainide acetate for the treatment of ventricular arrhythmias. New England Journal of Medicine 305: 473–477.
Norwegian Multicenter Study Group. 1981. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New England Journal of Medicine 304: 801–807.
Detre K, Peduzzi P, Murphy M, Hultgren H, Thomsen J, Oberman A, Takaro T. + Veterans Administration Co-operative Study Group for Surgery for Coronary Arterial Occlusive Disease. 1981. Effect of bypass surgery on survival in patients in low-risk and high-risk subgroups delineated by the use of simple clinical variables. Circulation 63: 1329–1338.
Hill JD, Hampton JR, Mitchell JRA. 1978. A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet is 837–841.
Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, Ryden L, Swedsberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C. 1981. Effect on mortality of metropolol in acute myocardial infarction. A double blind randomised trial. Lancet ii: 823–827.
Theroux P, Waters DD, Halphin C, Debaisieux J-C, Mizgala HF. 1979. Prognostic value of exercise testing soon after myocardial infarction. New England Journal of Medicine 301: 301–345.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Julian, D.G. (1982). Translating Results of Clinical Trials into Clinical Relevance. In: Roelandt, J., Hugenholtz, P.G. (eds) Long-Term Ambulatory Electrocardiography. Developments in Cardiovascular Medicine, vol 20. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7570-5_19
Download citation
DOI: https://doi.org/10.1007/978-94-009-7570-5_19
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7572-9
Online ISBN: 978-94-009-7570-5
eBook Packages: Springer Book Archive